Table 2.
Sociodemographic variables associations with knowledge, confidence and trust on COVID-19 vaccine clinical trials in Uganda.
| Parameter | Variable | N | Percentage Knowledge Score | Confidence Score | Trust Score | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mean ± SEM | ANOVA F (p) Value | Median (Min-Max) |
Mean ± SEM | ANOVA F(p) Value | Median (Min-Max) |
Mean ± SEM | ANOVA F(p) Value | Median (Min-Max) |
|||
| Age | >45 | 23 | 44.2 ± 3.4 | 0.603 (0.548) |
50 (16.7–66.7) | 2.5 ± 0.2 | 0.2 (0.814) |
2.4 (0.9–4.3) | 2.4 ± 0.2 | 1.4 (0.246) |
2.6 (0.4–3.8) |
| 25–45 | 166 | 41.4 ± 1.2 | 33.3 (0.0–83.3) | 2.5 ± 0.1 | 2.5 (0.3–4.6) | 2.2 ± 0.1 | 2.0 (0.0–5.0) | ||||
| <25 | 71 | 43.4 ± 2.1 | 33.3 (0.0–83.3) | 2.6 ± 0.1 | 2.7 (0.8–4.4) | 2.4 ± 0.1 | 2.2 (0.4–4.8) | ||||
| Gender | Female | 89 | 39.3 ± 1.5 | 4.3 (0.039) |
33.3 (0.0–66.7) | 2.6 ± 0.1 | 2.1 (0.147) | 2.5 (0.9–4.6) | 2.3 ± 0.1 | 0.1 (0.747) | 2.2 (0.4–5.0) |
| Male | 171 | 43.7 ± 1.3 | 50.0 (0.0–83.3) | 2.5 ± 0.1 | 2.5 (0.3–4.4) | 2.3 ± 0.1 | 2.0 (0.0–4.8) | ||||
| Marital status | Married | 118 | 42.7 ± 1.5 | 0.2 (0.666) | 33.3 (16.7–83.3) | 2.6 ± 0.1 | 0.7 (0.413) | 2.5 (0.3–4.4) | 2.4 ± 0.1 | 4.1 (0.045) | 2.4 (0.4–5.0) |
| Single | 142 | 41.8 ± 1.4 | 33.3 (0.0–83.3) | 2.5 ± 0.1 | 2.5 (0.8–4.6) | 2.2 ± 0.1 | 2.0 (0.0–4.8) | ||||
| Education level | Bachelors | 107 | 41.0 ± 1.4 | 2.3 (0.63) |
33.3 (0.0–83.3) | 2.5 ± 0.1 | 1.4 (0.239) |
2.5 (0.6–4.1) | 2.2 ± 0.1 | 6.6 (0.001) |
2.0 (0.4–4.2) |
| Certificate | 26 | 46.2 ± 3.2 | 50.0 (16.7–66.7) | 2.8 ± 0.2 | 2.8 (1.0–4.6) | 2.9 ± 0.3 | 3.0 (0.4–5.0) | ||||
| Diploma | 47 | 46.1 ± 2.6 | 50.0 (16.7–83.3) | 2.5 ± 0.1 | 2.5 (1.0–4.4) | 2.4 ± 0.1 | 2.0 (0.6–4.8) | ||||
| None | 8 | 31.3 ± 6.6 | 33.3 (0.0–50) | 3.1 ± 0.4 | 3.1 (1.6–3.9) | 3.1 ± 0.4 | 3.0 (2.0–4.8) | ||||
| Postgraduate | 72 | 41.2 ± 1.9 | 33.3 (16.7–83.3) | 2.5 ± 0.1 | 2.5 (0.3–4.6) | 2.0 ± 0.1 | 2.0 (0.0–3.4) | ||||
| Occupation | Clinician | 34 | 39.7 ± 2.4 | 0.4 (0.825) |
33.3 (16.7–83.3) | 2.1 ± 0.1 | 3.5 (0.009) |
2.2 (0.3–3.6) | 2.1 ± 0.1 | 6.6 (0.001) |
2.0 (0.6–3.6) |
| Laboratory personnel | 80 | 42.5 ± 1.8 | 50.0 (0.0–83.3) | 2.5 ± 0.1 | 2.5 (0.8–4.3) | 1.9 ± 0.1 | 2.0 (0.0–4.4) | ||||
| Nurse | 29 | 42.5 ± 3.3 | 50.0 (16.7–83.3) | 2.5 ± 0.1 | 2.5 (1.0–4.1) | 2.5 ± 0.1 | 2.5 (1.2–5.0) | ||||
| Pharmacist | 23 | 44.9 ± 3.2 | 50.0 (16.7–83.3) | 2.4 ± 0.2 | 2.3 (0.9–4.6) | 2.2 ± 0.2 | 2.0 (1.0–4.0) | ||||
| Support staff | 94 | 42.0 ± 1.8 | 33.3 (0.0–83.3 | 2.7 ± 0.1 | 2.7 (0.6–4.6) | 2.6 ± 0.1 | 2.4 (0.4–4.8) | ||||
| Location | Central | 101 | 42.4 ± 1.5 | 1.8 (0.144) |
50 (16.7–83.3) | 2.5 ± 0.1 | 6.4 (0.001) |
2.5 (0.9–4.6) | 2.1 ± 0.1 | 10.8 (0.001) |
2.0 (0.4–4.4) |
| Eastern | 72 | 44.9 ± 1.9 | 50 (0.0–83.3) | 2.8 ± 0.1 | 2.9 (0.8–4.4) | 2.8 ± 0.1 | 2.8 (0.6–5.0) | ||||
| Northern | 25 | 36.7 ± 3.2 | 33.3 (16.7–83.3) | 2.2 ± 0.2 | 2.1 (0.9–3.4) | 2.4 ± 0.2 | 2.2 (1.2–3.8) | ||||
| Western | 62 | 40.9 ± 2.3 | 33.3 (0.0–83.3) | 2.3 ± 0.1 | 2.4 (0.3–4.1) | 2.0 ± 0.1 | 2.0 (0.0–3.8) | ||||
| Preferred COVID-19 vaccine | DRV | 41 | 42.3 ± 2.9 | 1.2 (0.319) |
33.3 (16.7–83.3) | 2.5 ± 0.1 | 1.0 (0.412) |
2.5 (0.6–4.1) | 2.2 ± 0.1 | 3.1 (0.018) |
2.0 (0.8–4.0) |
| HV | 38 | 46.9 ± 2.8 | 50 (16.6–83.3) | 2.7 ± 0.1 | 2.6 (1.3–4.3) | 2.5 ± 0.2 | 2.6 (0.8–4.6) | ||||
| IV | 89 | 41.0 ± 1.5 | 33.3 (0.0–83.3) | 2.5 ± 0.1 | 2.5 (0.8–4.6) | 2.1 ± 0.1 | 2.0 (0.0–4.2) | ||||
| LAV | 35 | 39.5 ± 2.5 | 33.3 (16.7–83.3) | 2.5 ± 0.1 | 2.6 (0.9–4.3) | 2.3 ± 0.2 | 2.2 (0.4–4.4) | ||||
| None | 57 | 42.2 ± 1.0 | 33.3 (0.0–83.3) | 2.4 ± 0.1 | 2.4 (0.3–4.6) | 2.6 ± 0.2 | 2.4 (0.6–5.0) | ||||
KEY: DRV = DNA Recombinant vaccines, HV = Herbal treatments, IV = Inactivated vaccines, LAV = Live attenuated vaccines. N = number of participants, SEM = Standard error mean, Min-Max = Minimum-Maximum values, ANOVA = Analysis of variance, P-probability value.